Immunosuppression

Immunosuppression refers to a state of reduced immune system function — diminished ability to detect and respond to pathogens, abnormal cells, and foreign antigens. It can be intentionally induced with drugs to treat immune-mediated diseases, or it can occur as an unintended consequence of disease, malnutrition, stress, or aging.

Drug-Induced Immunosuppression

Intentional immunosuppression is a cornerstone of treating conditions where the immune system attacks the body’s own tissues:

Glucocorticoids (prednisone, dexamethasone): The most commonly used immunosuppressants. At immunosuppressive doses (2-4 mg/kg/day prednisone), they broadly suppress T-cell function, cytokine production, and inflammatory cell migration.

Cyclosporine: Calcineurin inhibitor that selectively suppresses T-cell activation. Used for atopic dermatitis, immune-mediated diseases, and inflammatory conditions.

Azathioprine: Purine analog that inhibits lymphocyte proliferation. Often used as a steroid-sparing agent for IMHA and IBD.

Mycophenolate mofetil: Inhibits lymphocyte proliferation via a different pathway than azathioprine. Increasingly used for refractory immune-mediated diseases.

Chemotherapy agents: Most cytotoxic drugs (doxorubicin, cyclophosphamide, vincristine) cause immunosuppression as a side effect of their anti-cancer activity, primarily through neutropenia and lymphopenia.

Disease-Related Immunosuppression

Several conditions inherently impair immune function:

• Cancer: Lymphoma and other hematologic malignancies directly compromise immune cell populations. Solid tumors create immunosuppressive microenvironments.
• Cushing’s disease: Chronic cortisol excess suppresses immune function, predisposing to UTIs, skin infections, and respiratory infections.
• Severe malnutrition: Protein-calorie deficiency impairs lymphocyte function and antibody production.
• Chronic stress: Sustained cortisol elevation from chronic pain, anxiety, or environmental stress reduces immune competence.

Age-Related Immunosenescence

Aging is associated with progressive immune decline (immunosenescence): reduced naive T-cell production, impaired vaccine responses, and weakened pathogen surveillance. This is why senior dogs are more susceptible to infections and why cancer incidence increases with age. Immunosenescence is distinct from drug-induced immunosuppression but compounds its effects in older dogs receiving immunosuppressive therapy.

Monitoring Immunosuppressed Dogs

Dogs on immunosuppressive therapy require:

• Regular CBCs: monitoring white blood cell counts, particularly neutrophil counts (neutropenia below 2,000/uL increases infection risk significantly)
• Urinalysis with culture: UTIs are common and may be subclinical
• Awareness of atypical infections: immunosuppressed dogs can develop opportunistic infections (fungal, protozoal) rare in immunocompetent animals
• Vaccination considerations: live vaccines are contraindicated during immunosuppression; killed vaccines may produce suboptimal responses

Relevance to Longevity

Managing the balance between necessary immunosuppression (to control immune-mediated disease) and infection risk is one of the most important therapeutic challenges in veterinary internal medicine. Using the minimum effective immunosuppressive dose, employing targeted agents over broad-spectrum ones, and maintaining rigorous health monitoring all help preserve immune competence and reduce infection-related morbidity in dogs requiring long-term immunosuppressive therapy.

Related reads

• Spay/Neuter (Gonadectomy)